ArticleInternational journal of clinical and experimental pathology2018

MeCP2 level is associated with hepatocellular carcinoma development in chronic hepatitis B patients under antiviral therapy.

Yun Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.